Beth Harrison

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

Alicia León‐Castillo, Ester Gilvazquez, Remi A. Nout et al. · The Journal of Pathology · 2019 · 376 citations · Full text

Molecular Characterisation, Tumoral Pathology, Medicine +12

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

Tjalling Bosse, Remi A. Nout, Jessica N. McAlpine et al. · The American Journal of Surgical Pathology · 2018 · 330 citations · Full text

Nsmp 69, Prognostic Evaluation, Medicine +11

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Stella Bowcock, Tim Planche et al. · The Lancet Oncology · 2019 · 151 citations · Full text

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Emily Reisenbichler, Gang Han, Andrew M. Bellizzi et al. · Modern Pathology · 2020 · 129 citations · Full text

Breast Oncology, Cancer Detection, Patient Selection +9

Pan-TRK Immunohistochemistry

Beth Harrison, Elizabeth Fowler, Gregor Krings et al. · The American Journal of Surgical Pathology · 2019 · 67 citations

Tumoral Pathology, Oncology, Breast Oncology +10